Most Read Articles
Roshini Claire Anthony, 5 days ago

Individuals with moderate-to-severe plaque psoriasis may reap better long-term improvements in the severity of their condition when treated with guselkumab over secukinumab, according to findings of the phase III ECLIPSE* trial presented at the recent Inflammatory Skin Disease Summit (ISDS 2018) held in Vienna, Austria.

Jairia Dela Cruz, 11 Jan 2019
Use of standard-dose aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) appears to confer protection against the risk of endometrial cancer in overweight and obese women, according to a meta-analysis.
4 days ago
Discontinuing the use of tyrosine kinase inhibitors (TKIs) in the treatment of patients with chronic myeloid leukaemia appears to be feasible in real-life clinical practice in the context of close molecular monitoring, a study reports.
5 days ago
There appears to be no clear link between pornography use, even at problematic levels, and erectile dysfunction, a recent US study has shown.

Direct-acting antivirals do not accelerate recurrence of hepatitis C-related HCC

23 Dec 2018

Using direct-acting antivirals (DAA) in treating chronic hepatitis C does not seem to accelerate the recurrence of hepatitis C-related hepatocellular carcinoma (HCC) after curative therapy, a new study has shown.

The study included 147 patients (median age 74.4 years; 59 percent male) successfully treated with radiofrequency ablation for hepatitis C- related HCC and who received antiviral treatment with DAAs. A comparison group of 156 patients (median age 65.3 years; 75 percent male) treated with interferon (IFN)-based therapy was also included.

Over a median observation period of 1.8 years, 80 patients in the DAA group developed HCC recurrence. The resulting 1- and 2-year tumour recurrence rates were 39 percent and 60 percent, respectively. In comparison, 136 recurrence events were recorded over 7.2 observation years in the IFN group, resulting in 1- and 2-year recurrence rates of 39 percent and 61 percent, respectively (p=0.43).

Recurrence patterns did not significantly differ between the DAA and IFN groups (chi-squared test p=0.70). For instance, intrahepatic recurrence of up to three tumours <3 cm in diameter occurred in 85 percent and 84 percent of the IFN- and DAA-treated patients, respectively.

Moreover, extrahepatic metastases were recorded in one patient who received IFN treatment and in two who were given DAAs.

Multivariate Cox proportional hazard regression analysis identified a larger number of HCC treatments and a shorter time between the last HCC treatment and initiation of antiviral therapy as independent risk factors for HCC recurrence.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 5 days ago

Individuals with moderate-to-severe plaque psoriasis may reap better long-term improvements in the severity of their condition when treated with guselkumab over secukinumab, according to findings of the phase III ECLIPSE* trial presented at the recent Inflammatory Skin Disease Summit (ISDS 2018) held in Vienna, Austria.

Jairia Dela Cruz, 11 Jan 2019
Use of standard-dose aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) appears to confer protection against the risk of endometrial cancer in overweight and obese women, according to a meta-analysis.
4 days ago
Discontinuing the use of tyrosine kinase inhibitors (TKIs) in the treatment of patients with chronic myeloid leukaemia appears to be feasible in real-life clinical practice in the context of close molecular monitoring, a study reports.
5 days ago
There appears to be no clear link between pornography use, even at problematic levels, and erectile dysfunction, a recent US study has shown.